Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year
A Regeneron Pharmaceuticals drug that lowers levels of a disease-driving protein has met the goals of a pivotal test in ...
A Regeneron Pharmaceuticals drug that lowers levels of a disease-driving protein has met the goals of a pivotal test in ...
WASHINGTON — The Food and Drug Administration announced Friday that it has begun publishing reports of adverse events concerning drugs ...
The US Food and Drug Administration (FDA) is warning consumers to avoid sunscreens sold in whipped, mousse, or foam forms, ...
Pfizer’s Covid vaccine for young children may not be renewed by the US Food and Drug Administration (FDA) this fall, ...
The Food and Drug Administration will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and ...
The U.S. Food and Drug Administration was slammed recently for overhyping its disclosure of a set of rejection notices it ...
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign ...
For decades, the Food and Drug Administration has partnered with clinicians and industry to deliver evidence-based medical innovations using a ...
Capricor Therapeutics’ cell therapy for Duchenne muscular dystrophy has come up short at the FDA, with the regulator rejecting the ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.